SecBot SecBot
8-K ·Filed May 5, 2026

AHCO

AdaptHealth Corp.
MIXED
Impact 6/10
Horizonweeks Processed6mo ago SEC0001628280-26-030120
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The revenue beat and raised guidance are positive, but the GAAP EPS miss, declining Adjusted EBITDA, deeply negative FCF, and COO departure create a mixed picture. Watch the Q2 2026 call for evidence that the $12M in elevated labor costs normalize and that the new capitated contract drives margin recovery. The $1.1B refinancing reduces near-term debt risk.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$11.75
T+0 close · May 5, 2026 · via day close
Latest settled
−9.11%
T+60 · $10.68
Vs SPY
−11.85%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 5 $11.75entry
  2. T+1 · 7mo ago −2.81%α −4.19% · $11.42
  3. T+5 · 6mo ago −4.26%α −6.24% · $11.25
  4. T+20 · 6mo ago −17.87%α −22.83% · $9.65
  5. T+60 · 4mo ago −9.11%α −11.85% · $10.68

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AdaptHealth reported Q1 2026 revenue of $819.8M (+5.4% YoY), beating the $796.6M consensus, but GAAP EPS was -$0.12, a miss vs the $0.01 consensus. Adjusted EBITDA declined 5.3% to $121.2M and free cash flow was deeply negative at -$27.5M. Revenue guidance was raised by $10M to $3.45B-$3.52B, but EBITDA and FCF guidance were maintained. The COO was terminated and replaced internally. The combination of a GAAP EPS miss, declining profitability, negative FCF, and a C-suite departure tempers the positive revenue beat and guidance raise.

Key Financial Metrics

EPS
−$0.12
est $0.01 · -1300.0%
Revenue
$819.8M
est $796.6M · +2.9% · +5.4% YoY
Rating
miss
Guidance
$3.45B-$3.52B
raised
Free Cash Flow
-$27.5M
Gross Margin
13.6%

Key Facts

  • Q1 2026 net revenue $819.8M, +5.4% YoY from $777.9M, above $796.6M consensus
  • GAAP diluted EPS -$0.12 vs consensus $0.01, a significant miss
  • Net loss attributable to AdaptHealth widened to -$16.0M from -$7.2M YoY
  • Adjusted EBITDA fell 5.3% to $121.2M from $127.9M; margin contracted to 14.8% from 16.4%
  • Free cash flow was -$27.5M vs -$0.1M YoY, driven by $121.2M in capex
  • FY 2026 revenue guidance raised by $10M to $3.45B-$3.52B; EBITDA and FCF guidance maintained
  • COO Toby Scott Barnhart terminated May 4, 2026; replaced by Daniel McFadden (internal)
  • Completed $1.1B refinancing of senior secured credit facility in April 2026
  • Organic revenue growth of 9.1%, with growth across all four segments
  • Cash balance fell to $48.0M from $106.1M at year-end 2025

Financial Impact

Revenue beat of ~$23M vs consensus but GAAP EPS miss of -$0.13; Adjusted EBITDA down $6.7M YoY; FCF swing of -$27.4M

revenueepsadjustedEbitdafreeCashFlow

Risk Factors

  • GAAP profitability continues to deteriorate, net loss widened 123% YoY
  • Free cash flow deeply negative at -$27.5M, requiring debt or equity to fund capex
  • COO termination could signal operational execution challenges with the new capitated contract
  • Cash balance halved to $48M, reducing financial flexibility

Market Snapshot

Exchange
Nasdaq
Sector
Services-Home Health Care Services
Analyst Consensus
79% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-030120
Document: ahco-20260505.htm0001628280-26-030120
Document: 0001628280-26-030120-index-headers.html0001628280-26-030120
Document: 0001628280-26-030120-index.html0001628280-26-030120
Document: 0001628280-26-030120.txt0001628280-26-030120
8-K Data (Synthetic)0001628280-26-030120

Track record

20 reports on AHCO

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +47.49% at T+60 after the Jul 2, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 3/10 Entry $7.80 Now $7.73 −0.90% settles Nov 18
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $7.89 Now $7.73 −2.03% settles Nov 17
  3. Nov 12, 20264d ago 144 Neutral 3/10 Entry $7.87 to $7.66 Now $7.73 −1.78% ▼ −2.67% −2.31% vs SPY
  4. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $7.35 to $7.72 Now $7.73 +5.17% ▲ +5.03% +5.40% vs SPY
  5. Nov 6, 202610d ago 144 Neutral 2/10 Entry $7.35 to $7.72 Now $7.73 +5.17% ▲ +5.03% +5.40% vs SPY
  6. Nov 5, 202611d ago 144 Neutral 3/10 Entry $7.33 to $7.35 Now $7.73 +5.46% ▲ +0.27% −2.09% vs SPY
  7. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $7.41 to $7.33 Now $7.73 +4.32% ▼ −1.08% −1.39% vs SPY
  8. Nov 3, 202613d ago 8-K Mixed 6/10 Entry $6.28 to $7.31 Now $7.73 +23.09% ▲ +16.40% +14.75% vs SPY
  9. Oct 29, 202619d ago Court Ruling Neutral 2/10 Entry $5.81 to $5.91 Now $7.73 +33.05% ▲ +1.72% +2.20% vs SPY
  10. Oct 13, 20264w ago SC 13G/A Bearish 4/10 Entry $6.33 to $6.25 Now $7.73 −22.12% ▲ +1.26% +0.18% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 8h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026